The Theory of Medical Irreversibility

Modern medicine assumes reversibility as an implicit premise: that sufficiently early or aggressive intervention can restore health. This paper challenges that assumption by introducing the Theory of Medical Irreversibility (TMI), grounded in the Theorem of Axiomatic Necessity (TNA). We propose that diverse pathologies—cancer, neurodegeneration, and aging—share a common failure mode: collapse of dissipative throughput (Ψ) below a critical threshold, beyond which biological systems undergo functional closure and entropic regression. While genetic mutations, protein aggregation, or cellular senescence may initiate instability, they do not govern late-stage destiny. Once export of entropy becomes insufficient, pathology transitions from a molecular problem to a thermodynamic regime. At this point, additional intervention may slow deterioration but cannot restore prior structural coherence (N¹). This framework explains why mutation-centric oncology fails in late-stage cancer, why plaque clearance does not reverse neurodegeneration, and why longevity interventions lose efficacy beyond a critical age. Medical irreversibility is therefore not disease-specific, but a system-level phase transition governed by throughput dynamics. Recognizing this boundary redefines therapeutic goals—from cure to stabilization—and establishes a unifying law across biological collapse.